Denmark has suspended the AstraZeneca vaccine for two weeks following reports of blood clots forming, as well as one death.
A batch of the vaccine was also suspended in Austria while an investigation into a death from coagulation disorders and an illness from a pulmonary embolism is underway.
Danish authorities have not stated how many blood clot reports there are at the moment. AstraZeneca and the European Medicines Agency (EMA) have made no comment on the situation yet.
The EMA added that there was no current evidence linking the side-effects to the AstraZeneca vaccine, stating that the number of people who reported thromboembolic effects after receiving the AstraZeneca vaccine was no higher than what is seen in the general population.